Skip to content

Very early antiretroviral treatment limits the size of HIV reservoir

Dr Jintanat Ananworanich of SEARCH Thailand presenting at CROI 2013.

Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

Edward Gane presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Consistent condom use in anal sex stops 70% of HIV infections, study finds

Dawn Smith of the US Centers for Disease Control (CDC) presenting at CROI 2013.

Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

Chasity Andrews, of the Aaron Diamond AIDS Research Center, presenting at CROI 2013.

VOICE trial: disappointing result poses big questions for PrEP

Jeanne Marrazzo discusses results of the VOICE study at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Case report of a 'functional' HIV cure in a child

Deborah Persaud from Johns Hopkins University School of Medicine.  © Liz Highleyman / hivandhepatitis.com

US gay youth PrEP study meets recruitment and adherence problems

In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis